Abel Hall LLC’s Twist Bioscience TWST Stock Holding History

Abel Hall LLC’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$548K	Buy	5,323 +314	+6%	+$20.4K	0.09%	211
2026 Q1	$238K	Buy	+5,009	New	+$225K	0.05%	526

Other funds holding TWST

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Abel Hall LLC's TWST Position: Q2 2026 in Review

Abel Hall LLC increased its Twist Bioscience (TWST) stake by 6.3% in Q2 2026, buying an estimated $20.4K and bringing the position to 5,323 shares worth $548K. The position accounts for 0.09% of the portfolio, ranked #211.

Abel Hall LLC first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Abel Hall LLC held 5,323 shares of Twist Bioscience worth $548K as of Q2 2026.
Abel Hall LLC bought 314 Twist Bioscience shares in Q2 2026, an estimated $20.4K.
Twist Bioscience made up 0.09% of Abel Hall LLC's portfolio in Q2 2026, its #211 holding.
Abel Hall LLC first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
65 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.